(Q45045271)

English

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

scientific article published on 2 September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

(RS)-rabeprazole

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kerstin Röhss

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Tore Lind

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Clive Wilder-Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

2 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

60

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

531-539

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heartburn--the acid test

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of the 24-hour intraesophageal pH monitoring composite scoring system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of pH control in the management of GERD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress with proton pump inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15349707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-004-0804-6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45045271&oldid=2207065533"